Should Telehealth Be Adopted as a Global Practice?

With constantly evolving technology allowing us to stay connected wherever we are, Telehealth has become forefront due to the Coronavirus pandemic.

However, even before the onset of the pandemic, this is something that was being trialled and used in many countries around the world. In 2019 Germany passed the Digital Healthcare Act with a view to move towards digitisation and innovation in the future. 

While there are many clear benefits to using these new methods, especially during a global pandemic do you think that a proper set of rules and regulations should be rolled out worldwide to avoid any missteps and potential abuse of the systems?

In March 2021, we surveyed 560 M3 members about this important topic.

Would you like to receive the M3 Pulse directly to your inbox and take part in paid market research?

Join M3 Global Research

Share your opinion and get rewarded

Register as healthcare professional


  1. no it should not be , one on one is very important from the diagnostic point of view to say the least, interactive communication was ,is will always be critical

  2. Telehealth has always been the best and quickest way of receiving care at your convenience for those that are far and still need to receive the services…I therefore suggest very much need for telehealth

  3. Telehealth is an advanced practice to assess and examine patients and has been useful in these times of pandemic, however, for now, it can’t be taken as a substitute of traditional medical practice as a major part of diagnosis of a disease is related to inspecting, examining and assessing patient which is not possible through telehealth.

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.